VMIH-associated contributors are underlined.

JOURNAL ARTICLE: Liu H, Chen MZ, Payne T, Porter CJ, Pouton CW, Johnston AP. Beyond the Endosomal Bottleneck: Understanding the Efficiency of mRNA/LNP Delivery. Adv. Funct. Mater. 2024, 2404510. https://doi.org/10.1002/adfm.202404510

JOURNAL ARTICLE: Chen MZ, Yuen D, McLeod VM, Yong KW, Smyth CH, Rossi Herling B, Payne TJ, Fabb SA, Belousoff MJ, Algarni A, Sexton PM, Porter PJH, Pouton CW, Johnston APR. A Versatile Antibody Capture System that Drives Precise In Vivo Delivery of mRNA loaded Lipid Nanoparticles and Enhances Gene Expression. bioRxiv 2024.08.07.607101; doi: https://doi.org/10.1101/2024.08.07.607101

JOURNAL ARTICLE: Chen J, Cortez-Jugo C, Kim C-J, Lin Z, Wang T, De Rose R, Xu W, Wang Z, Gu Y, Caruso F. Metal-Phenolic-Mediated Assembly of Functional Small Molecules into Nanoparticles: Assembly and Bioapplications. Angew. Chem. Int. Ed. 2024, 63, e202319583.Angew. Chem. Int. Ed. 2024, 63, e202319583. https://doi.org/10.1002/anie.202319583

JOURNAL ARTICLE: Gail EH, Healy E, Flanigan SH, Jones N, Ng XH, Uckelmann M, Levina V, Zhang Q, Davidovich C. Inseparable RNA binding and chromatin modification activities of a nucleosome-interacting surface in EZH2. Nature Genetics. 2024 DOI:10.1038/s41588-024-01740-8.

JOURNAL ARTICLE: Takanashi A, Pouton CW*, and Al-Wassiti H*. Delivery and Expression of mRNA in the Secondary Lymphoid Organs Drive Immune Responses to Lipid Nanoparticle-mRNA Vaccines after Intramuscular Injection. Mol. Pharmaceutics 2023, 20, 8, 3876–3885.

JOURNAL ARTICLE: Ohtomo H, Ito S, McKenzie NJ, Uckelmann M, Wakamori M, Ehara H, Furukawa A, Tsunaka Y, Shibata M, Sekine S-I, Umehara T, Davidovich C, Koseki H, Nishimura Y. H2A Ubiquitination Alters H3-tail Dynamics on Linker-DNA to Enhance H3K27 Methylation. J Mol Biol. 2023 435(4):167936.

JOURNAL ARTICLE: Nolan TM, Deliyannis G, Griffith M, Braat S, Allen LF, Audsley J, Chung AW, Ciula M, Gherardin NA, Giles ML, Gordon TP, Grimley SL, Horng L, Jackson DC, Juno JA, Kedzierska K, Kent SJ, Lewin SR, Littlejohn M, McQuilten HA, Mordant FL, Nguyen THO, Soo VP, Price B, Purcell DFJ, Ramanathan P, Redmond SJ, Rockman S, Ruan Z, Sasadeusz J, Simpson JA, Subbarao K, Fabb SA, Payne TJ, Takanashi A, Tan CW, Torresi J, Wang JJ, Wang LF, Al-Wassiti H, Wong CY, Zaloumis S, Pouton CW, Godfrey DI. Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose booster. EBioMedicine. 2023 Dec;98:104878. doi: 10.1016/j.ebiom.2023.104878. Epub 2023 Nov 27. PMID: 38016322; PMCID: PMC10696466.